{
  "docId": "019de075-8a55-750a-8008-603750933d71",
  "docSlug": "da8608bdf4ad385699d1340db7dce185",
  "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
  "authorId": "erasca",
  "authorName": "Erasca",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 21,
  "pageCount": 56,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "traction",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 15,
  "notes": "The diagram uses a tree structure to categorize patient outcomes (off treatment vs on treatment, further broken down by SD and PR).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-8a55-750a-8008-603750933d71/21",
  "deckHref": "/decks/019de075-8a55-750a-8008-603750933d71",
  "deckJsonHref": "/decks/019de075-8a55-750a-8008-603750933d71.json",
  "deckAnchorHref": "/decks/019de075-8a55-750a-8008-603750933d71#slide-21",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.35,
        "x": 0.33,
        "y": 0.75
      },
      "kind": "callout",
      "text": "Patients with SD at, or on track, for delayed progression > 4 months could contribute to PFS benefit vs. SOC",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2f703803-7d4f-4dd1-a723-22a06f458c21",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.78,
        "x": 0.11,
        "y": 0.185
      },
      "kind": "diagram",
      "text": "24 enrolled -> 15 off treatment / 9 on treatment -> 4 SDs / 5 PRs",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ba328e60-1104-4818-a90b-f3bded5e5352",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.35,
        "x": 0.03,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "*includes unconfirmed responses\nSource: annotated LXH254C12201 Ph 2 trial data from Lebbe et al, ESMO 2022",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d9c0f8ab-70bf-440d-8461-886ed7f1b31b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.94,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "Phase 2 patients continuing on treatment on naporafenib + trametinib = potential for confirmation of Ph 1 DOR and PFS advantage in SEACRAFT-2",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c8973da-8774-44c3-b999-898b97d3a449",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "ce6f3500-1e58-42fe-876f-35d9b82da450",
      "evidence": "The slide mentions 'Patients with SD at, or on track, for delayed progression > 4 months could contribute to PFS benefit vs. SOC', indicating a focus on a specific audience or patient segment.",
      "confidence": 0.7
    },
    {
      "name": "Data Story Arc",
      "slug": "data-story-arc",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "4dbf4b7d-a7cb-47de-9413-8cd03aa14756",
      "evidence": "The slide presents data and a diagram showing the potential for confirmation of Ph 1 DOR and PFS advantage in SEACRAFT-2, telling a story with the data.",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}